That's not good for Acrux. But a glance at the KV accounts suggests there's no danger of KV failing. And I think Evamist is being marketed under a different brand, so there shouldn't be any direct effect.
Having so many products - seven in total - partnered with the one company is a risk. It would be good to see some deals being done with other companies.
